Long COVID: Clinical Trials

244 trials for Long COVID, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

107 completed, 48 recruiting, 39 unknown, 19 active not recruiting. 105 Not applicable, 59 Phase 2, 16 Phase 3, 8 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable105Completed 47, Recruiting 21, Unknown 15, Not yet recruiting 8, Active not recruiting 7, Enrolling by invitation 2, Suspended 2, Withdrawn 2, Terminated 1
Phase 259Completed 31, Recruiting 12, Unknown 6, Not yet recruiting 5, Active not recruiting 4, Withdrawn 1
Phase 316Completed 5, Recruiting 5, Active not recruiting 2, Not yet recruiting 2, Unknown 2
Phase 18Recruiting 3, Completed 2, Unknown 2, Not yet recruiting 1
Early Phase 11Suspended 1
Phase 41Terminated 1

Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Taurine Supplementation in Adolescents With Post-COVID Condition
Taurine - Long COVID, Post COVID-19 Condition
Phase 1 / Phase 2Not yet recruitingUniversity of Alberta302026-12-302026-10-16
Fatigue in Long COVID
Lightning Process, Activity Pacing - Long COVID
Not applicableNot yet recruitingMcMaster University1002026-11-012026-07-13
Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome
VYD2311, Placebo - Long COVID, COVID-19 (SARS-CoV-2 Infection)
Phase 2Not yet recruitingInvivyd, Inc.1302026-10-012026-10-27
Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue
Transcranial Direct Current Stimulation - Long COVID, Post-COVID Conditions
Not applicableNot yet recruitingUniversity of Las Palmas de Gran Canaria202026-09-152026-07-22
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)
Post-Acute Sequelae of COVID-19 (PASC) Assessment - Long COVID, COVID-19
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS9002026-09-012026-08-14
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID
Not yet recruitingTamara C Tamas502026-08-012025-12-02
Sauna for Long Covid
whole body hyperthermia - Long COVID
Not applicableRecruitingMassachusetts General Hospital212026-08-012025-11-13
Cognitive Impairment and Return to Work in Long COVID
Long COVID
CompletedHopitaux de Saint-Maurice552026-08-012026-10-19
A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID, a course of individually tailored treatment by a homeopath - Long COVID, Long COVID Symptoms
Not applicableNot yet recruitingSt. Mary's University, Twickenham1202026-07-152026-07-09
A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mg, Placebo, Maraviroc - Long COVID
Phase 2 / Phase 3Not yet recruitingHealthBio, Inc.2522026-07-152026-06-18
Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Rauha® Digital Therapeutic Platform (Toivoa-004) - Long Covid, Depression
Not applicableWithdrawnToivoa Inc2026-07-012026-07-29
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Valacyclovir, Celecoxib, Paxlovid - Post-acute Sequelae of COVID-19, Long COVID
Phase 2Not yet recruitingIcahn School of Medicine at Mount Sinai1502026-06-012026-05-19
Fatigue Investigation Using Digital Outcomes
Multiple Sclerosis, Long Covid
RecruitingLiliana Barrios1222026-05-262026-08-24
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Paragon Novel Metabolic Regulator (PNMR), Dietary and Lifestyle Recommendations - Long COVID
Phase 2RecruitingParagonClinicals Inc.822026-05-202026-06-04
Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)
Long Covid
RecruitingUniversity of California, San Francisco1502026-05-182026-08-18
Understanding the Long-term Impact of COVID-19 in Adults
Long COVID, Long Covid19
Not yet recruitingNYU Langone Health52052026-05-012026-03-27
The Effect of Acupuncture Treatment on Cognitive Functions and Brain Networks for Long COVID
Acupuncture, Sham acupuncture - Long Covid
Not applicableNot yet recruitingTingting Luo1082026-05-012026-01-21
PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
PERCEIVE-Outreach Disease Management Program - Long COVID
Not applicableRecruitingUniversity of Tasmania5772026-04-012026-10-06
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
REGENECYTE, Placebo - Long COVID, Post-COVID-19 Condition
Phase 3Not yet recruitingStemCyte, Inc.602026-03-312025-09-23
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Kisspeptin 112-121 - Reproductive Disorder, Neurodegeneration
Phase 1RecruitingStephanie B. Seminara, MD402026-03-102026-07-13

Showing 20 of 244. Sign in to see all of them.

Narrower conditions

Post-Acute COVID-19 Syndrome (244)  ·  COVID-19 (57)  ·  Fatigue (18)  ·  Mental Fatigue (18)  ·  Motor Activity (14)  ·  Fatigue Syndrome, Chronic (12)  ·  Cognitive Dysfunction (8)  ·  Depression (7)  ·  Postural Orthostatic Tachycardia Syndrome (7)  ·  Anxiety Disorders (6)  ·  Asthma (6)  ·  Autonomic Nervous System Diseases (6)  ·  Dyspnea (6)  ·  Multiple Sclerosis (5)  ·  Pain (5)

Broader conditions

Coronaviridae Infections (244)  ·  Disease Attributes (244)  ·  Lung Diseases (244)  ·  Nidovirales Infections (244)  ·  Pathologic Processes (244)  ·  Pathological Conditions, Signs and Symptoms (244)  ·  Pneumonia (244)  ·  Pneumonia, Viral (244)  ·  RNA Virus Infections (244)  ·  Respiratory Tract Infections (244)  ·  Virus Diseases (244)  ·  Chronic Disease (243)  ·  Infections (243)  ·  Post-Infectious Disorders (243)  ·  Respiratory Tract Diseases (243)

Interventions

Educational Status (4)  ·  Ritonavir (4)  ·  Acupuncture Therapy (3)  ·  Blood Specimen Collection (3)  ·  Hyperbaric Oxygenation (3)  ·  Transcranial Direct Current Stimulation (3)  ·  nirmatrelvir and ritonavir drug combination (3)  ·  ALT-803 (2)  ·  Amantadine (2)  ·  Bupivacaine (2)  ·  Cognitive Training (2)  ·  Exercise (2)  ·  Immunoglobulins, Intravenous (2)  ·  Ivabradine (2)  ·  Lithium (2)

Sponsors

Duke University (8)  ·  Icahn School of Medicine at Mount Sinai (5)  ·  Kanecia Obie Zimmerman (5)  ·  VA Office of Research and Development (5)  ·  University of Alberta (4)  ·  StemCyte, Inc. (3)  ·  University Health Network, Toronto (3)  ·  Beth Israel Deaconess Medical Center (2)  ·  Centre for Addiction and Mental Health (2)  ·  Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (2)  ·  Chengdu Sport University (2)  ·  European University Cyprus (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  ImmunityBio, Inc. (2)  ·  Karolinska Institutet (2)

Countries

United States (96)  ·  Canada (18)  ·  United Kingdom (15)  ·  Spain (13)  ·  Italy (12)  ·  Brazil (8)  ·  China (7)  ·  Germany (7)  ·  Austria (5)  ·  Belgium (5)  ·  France (5)  ·  Netherlands (5)  ·  Switzerland (5)  ·  Mexico (4)  ·  Taiwan (4)

Top investigators

Lucinda Bateman, MD (4)  ·  Barry Make, MD (3)  ·  Christina Barkauskas, MD (3)  ·  Cyndya Shibao, MD (3)  ·  Gary M Felker, MD (3)  ·  Janna Friedly, MD, MPH (3)  ·  Kanecia Zimmerman, MD PhD (3)  ·  Pam Taub, MD (3)  ·  Peter Novak, MD (3)  ·  Susan Redline, MD MPH (3)  ·  Tae Chung, MD (3)  ·  Angela M Cheung, MD, PhD (2)  ·  Christopher Grainger, MD (2)  ·  Daniel Laskowitz, MD MHS (2)  ·  David Putrino, PhD, PT (2)

Results publications

PMID 41720282, PMID 42282195, PMID 39356507, PMID 32644129, PMID 35059791, PMID 35571200, PMID 35816681, PMID 36446465, PMID 36806073, PMID 36833793, PMID 37270195, PMID 37868959, PMID 38102536, PMID 38173937, PMID 38755688, PMID 38802273, PMID 38848477, PMID 38879571, PMID 39493634, PMID 39536121, PMID 39571342, PMID 39592468, PMID 40188838, PMID 40334212, PMID 40495009, PMID 40622772, PMID 40730806, PMID 40810942, PMID 40894014, PMID 40940063, PMID 41212544, PMID 41253410, PMID 41316170, PMID 41625963, PMID 41650882, PMID 41748706, PMID 42017829, PMID 42118816, PMID 42136829, PMID 42243809, PMID 42415194, PMID 42447127, PMID 42498469, PMID 42533000, PMID 42547235, PMID 42577968, PMID 42653699, PMID 42673984, PMID 42790915

NIH funding

OT2HL156812 (3), 1OT2HL156812-01 (1), 2023 (1), 272201800011C-P00005-9999-1 (1), I01CX002668 (1), I21RX004092 (1), I21RX004409 (1), R01AG085873 (1), R01AG089307 (1), R01DC021179 (1), R34AT012679 (1), R37HD043341 (1), R43NR021082 (1), UL1TR001412 (1)